Proteome Sciences plc (AIM:PRM)
London · Delayed Price · Currency is GBP · Price in GBX 1.850
+0.095 (5.41%)
Feb 13, 2026, 3:46 PM GMT
Proteome Sciences Market Cap
Proteome Sciences has a market cap or net worth of 6.17 million as of February 13, 2026. Its market cap has decreased by -52.37% in one year.
Market Cap
6.17M
Enterprise Value
21.30M
Revenue
4.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.85
Market Cap Chart
Since March 1, 1999, Proteome Sciences's market cap has decreased from 11.17M to 6.17M, a decrease of -44.75%. That is a compound annual growth rate of -2.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.17M | -16.35% |
| Dec 31, 2025 | 7.38M | -26.47% |
| Dec 31, 2024 | 10.04M | -24.94% |
| Dec 29, 2023 | 13.37M | 29.43% |
| Dec 30, 2022 | 10.33M | -31.71% |
| Dec 31, 2021 | 15.13M | 32.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| OptiBiotix Health | 7.64M |
| Futura Medical | 7.39M |
| CRISM Therapeutics | 7.37M |
| Cizzle Biotechnology Holdings | 6.14M |